After this article was published, similarities were noted between this article [1] and submissions by other research groups which call into question the validity and provenance of the reported results. In light of these issues, the PLOS ONE Editors issue this Expression of Concern.
PLOS attempted to discuss the concerns with the authors, but the authors either did not reply or could not be reached through the email addresses on file with the journal.
Reference
- 1. Li J, Wang P, Xu Y (2017) Prognostic value of programmed cell death ligand 1 expression in patients with head and neck cancer: A systematic review and meta-analysis. PLoS ONE 12(6): e0179536. https://doi.org/10.1371/journal.pone.0179536 pmid:28604812
Citation: The PLOS ONE Editors (2022) Expression of Concern: Prognostic value of programmed cell death ligand 1 expression in patients with head and neck cancer: A systematic review and meta-analysis. PLoS ONE 17(11): e0278502. https://doi.org/10.1371/journal.pone.0278502
Published: November 28, 2022
Copyright: © 2022 The PLOS ONE Editors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.